Studies in small cohorts of patients with other thalassemic syndromes have given conflicting results: Taher et al. did not find the JAK2 V617F mutation in any of 36 Lebanese patients with thalassemia intermedia [10]. This evidence concerns the gene JAK2 and beta-thalassemia intermedia.